Dr. Christopher Hwang, MD

Dr. Hwang practices at CCHS Primary Care Practice PA in Newark, Delaware.

Dr. Hwang's NPI, 1912249061, was assigned on March 26, 2013. Dr. Hwang graduated from Jefferson Medical College of Thomas Jefferson University in 2013. Dr. Hwang holds Pennsylvania license MD456653.

Dr. Hwang's primary practice is CCHS Primary Care Practice PA, at 200 Hygeia Dr, Newark, DE 19713 in New Castle County. The practice phone is (302) 623-7362.

Dr. Hwang's primary practice is CCHS Primary Care Practice PA in Newark, Delaware. Dr. Hwang is also affiliated with Lankenau Medical Center. The medical group on file is Crozer Health Medical Group (CHMG). Dmand AI also links Dr. Hwang to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hwang practices, 4 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Hwang's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Hwang is licensed in Pennsylvania.

CMS data shows 875 Medicare services from Dr. Hwang across 16 procedure codes in 2024, for 280 Medicare patients. Medicare paid $55,452 for them.

CMS counts 280 Medicare patients who saw Dr. Hwang in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hwang's median patient age at 70, with 52% women.

In 2024, Dr. Hwang wrote 6,136 Medicare Part D claims for 498 patients. 84% of them were for generic drugs. CMS names the drug for 5,414 of them, across 121 drugs with 11 or more claims each, at $454,513 in total drug cost. In 2023, CMS named 4,785 claims across 118 drugs.

Dr. Hwang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hwang as offering telehealth.

Dmand AI links 21 papers to Dr. Hwang, published from 2011 to 2021. 2012 was the busiest year, with 3. The most frequent topics are Retina, Visual Acuity and Angiogenesis Inhibitors. Dr. Hwang has published most often in Ophthalmology. Dr. Hwang's most frequent co-authors are Tiarnan Keenan, Alexander J. Brucker, MD and Debora Hana Lee, MD.

CMS Open Payments shows 190 general payments to Dr. Hwang from 32 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $635.

Dr. Hwang graduated from Jefferson Medical College of Thomas Jefferson University in 2013.